MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

Status:
Completed

Trial end date:
2006-05-01

Target enrollment:

Participant gender:

To evaluate the safety and efficacy of SSR240600C versus placebo on clinical and cystometric parameters in patients with OAB and UUI.

Phase 2

Sanofi

Tolterodine Tartrate